收藏切换
Formulation Study and Process Scale-up of Solid Dispersions of Poorly Soluble Drug XNW14010 by Fluidized-bed Technology
收藏切换
Yinghui LIU, Ji ZHANG, Bao LI, Jinlian ZHU, Wengui WANG
Chinese Journal of Pharmaceuticals | 2024, 55(7) : 956 - 964
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2024, 55(7): 956-964
• Paper •
Formulation Study and Process Scale-up of Solid Dispersions of Poorly Soluble Drug XNW14010 by Fluidized-bed Technology
Full
Yinghui LIU, Ji ZHANG, Bao LI, Jinlian ZHU, Wengui WANG
Affiliations
  • Evopoint Biosciences Co., Ltd., Suzhou 215100
Published: 2024-07-10 doi: 10.16522/j.cnki.cjph.2024.07.009
Outline
收藏切换

The solid dispersions of a KRAS G12C covalent inhibitor, XNW14010, were prepared by fluidized-bed technology with mannitol particles as the substrates. The type and amount of the carriers and the amount of mannitol particles were optimized by the single factor experiments. The optimal formulation was using poly(vinylpyrrolidone-co-vinyl-acetate)(PVP-VA64) as the carriers, and the mass ratio of 1-PVP-VA64-mannitol particles was 1∶1∶1.2. By exploring and optimizing the key process parameters, the process of 1 solid dispersion was scaled up in the GMP workshop. The PXRD characterization results showed that 1 existed in an amorphous state in the solid dispersions. The SEM observation revealed that the solid dispersion particles were spherical in shape and formed an even coating layer around the mannitol substrate. Moreover, the angle of repose of the solid dispersion particles was less than 40°, making it suitable for further mixing and tableting. Based on this, a scale-up production of 1 solid dispersions-based tablets was successfully developed. In the in vitro dissolution test, the dissolution rate at 10 min of 1 from the solid dispersions-based tablets was close to 100% in pH 6.8 PBS. An in vivo experiment was carried out with Beagle dog as a model. The results showed that the drug exposure of 1 from the solid dispersions-based tablets was 8 times higher than that of 1 tablets.

XNW14010  /  poorly soluble drug  /  amorphous  /  solid dispersion  /  tablet  /  dissolution  /  pharmacokinetics  /  fluidized-bed technology  /  process scale-up
刘颖慧, 张霁, 李宝, 朱金莲, 王文贵. 流化床技术制备难溶性药物XNW14010固体分散体的处方开发及工艺放大. 中国医药工业杂志, 2024 , 55 (7) : 956 -964 . DOI: 10.16522/j.cnki.cjph.2024.07.009
Yinghui LIU, Ji ZHANG, Bao LI, Jinlian ZHU, Wengui WANG. Formulation Study and Process Scale-up of Solid Dispersions of Poorly Soluble Drug XNW14010 by Fluidized-bed Technology[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (7) : 956 -964 . DOI: 10.16522/j.cnki.cjph.2024.07.009
Year 2024 volume 55 Issue 7
26
6
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2024.07.009
  • Receive Date:2023-08-30
  • Online Date:2026-11-18
  • Published:2024-07-10
Article Data
Affiliations
History
  • Received:2023-08-30
Affiliations
    Evopoint Biosciences Co., Ltd., Suzhou 215100
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.07.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT